Amy1 Acetate and lsoamyl Acetate Amy1 Acetate: CIR Safety Assessment Summary
CIR safety assessment summary for Amy1 Acetate and lsoamyl Acetate Amy1 Acetate: ingredients reviewed, panel verdict, use concentration context, condition.
Amy1 Acetate and lsoamyl Acetate Amy1 Acetate appears in a CIR safety assessment covering Amy1 Acetate and lsoamyl Acetate Amy1 Acetate. The panel verdict for the report is safe. On the basis of the information included in this report, the CIR Expert Panel concludes that Amyl Acetate and lsoamyl Acetate are safe as presently used in cosmetic products.
| Field | CIR value |
|---|---|
| Primary ingredient | Amy1 Acetate and lsoamyl Acetate Amy1 Acetate |
| CIR verdict | safe |
| Report type | Final Report |
| Date | 1988 |
| CAS numbers | 628-63-7 |
| Conditions or carve-outs |
Ingredients Reviewed
The review scope matters because CIR conclusions often apply to an ingredient family rather than a single INCI name. In this report, the ingredient list includes Amy1 Acetate and lsoamyl Acetate Amy1 Acetate.
Safety Conclusion
The conclusion for Amy1 Acetate and lsoamyl Acetate Amy1 Acetate should be read as a CIR panel conclusion, not a regulatory limit. CIR assessments summarize expert-panel safety determinations for cosmetic use, while legal status still depends on the jurisdiction and product category.
Conditions
On the basis of the information included in this report, the CIR Expert Panel concludes that Amyl Acetate and lsoamyl Acetate are safe as presently used in cosmetic products.
Formulation Reading
For formula review, begin with the exact INCI identity and the ingredient group covered by the CIR assessment. If the material is Amy1 Acetate and lsoamyl Acetate Amy1 Acetate, the relevant comparison is whether the intended use aligns with the practices, concentration ranges, and conditions described in the CIR source.
The ingredient hub at Amy1 Acetate and lsoamyl Acetate Amy1 Acetate should carry the substance-level profile. This page is the report-level summary, keeping the conclusion, ingredient scope, and use-context language attached to the CIR source rather than treating the conclusion as a universal permission.
Why This Page Exists
CIR reviews are long documents, and the practical answer is usually buried in the conclusion and the table of current practices. This summary keeps those CIR facts in one indexable page for Amy1 Acetate and lsoamyl Acetate Amy1 Acetate, with source details retained at the bottom for audit.
Review Notes
The conservative reading is to keep Amy1 Acetate and lsoamyl Acetate Amy1 Acetate tied to the exact CIR report listed below. The ingredient family, panel conclusion, date, and any use-condition language belong together. A shorter ingredient-page snippet would lose that context.
This page gives the search-level answer while preserving the source-level caveat: CIR safety language is a panel assessment for cosmetic practices of use, not a universal legal permission across every jurisdiction or product category.
Source
- CIR report: Final Report on the Safety Assessment of Amy1 Acetate and lsoamyl Acetate Amy1 Acetate, as used in cosmetic
- CIR source file: pr149.pdf
- Extraction JSON: Source documentation archived.
- Conclusion page in CIR extraction: 12